Skip to main content

Prognostic Value of Tryptophan Load Test Followed by Serum Kynurenine Determination. It’s Comparison With Pyridoxal-5-phosphate, Kynurenine, Homocysteine and Neopterin Amounts

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 527))

Abstract

Tryptophan load test followed by serum kynurenine determination at fasting state and after L-tryptophan loading, as well as serum pyridoxal-5-phosphate (P-5-P), homocysteine and neopterin concentrations at fasting state have been examined in 30 healthy individuals and 87 patients with coronary heart disease (CHD), verified by coronary angiography. Received results have shown that low serum P-5-P concentration as well as P-5-P deficiency identified by tryptophan load test have been found in 78% of CHD patients, while increased homocysteine concentration above 15 µmol/L in 31.8%, and elevated neopterin concentration above 8.7 nmol/L in 32.1% of cases. It allows to conclude that a lot of CHD patients have P-5-P deficiency. Moreover P-5-P deficiency is an earlier indicator of CHD than increased homocysteine level above 15.tmol/L. Elevated serum neopterin concentration above 8.7 nmol/L may be a marker of coronary disease activity rather than a marker of the presence of CHD.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. V. Rudzite, G. Sileniece, and J. Jirgensons, Tryptophan ¡ª nicotinic acid pathway in cardiovascular diseases, in: Progress in Tryptophan and Serotonin Research, edited by H.G. Slossberger, W. Kochen, B. Linzen, and H. Steinhart (Walter de Gruyter, Berlin, New York, 1984), pp. 365-38I.

    Google Scholar 

  2. V. Rudzite, G. Sileniece, J. Jirgensons, J. Skards, R. Zime, and A. Dalmane, Bradyarrhytmias and myocardial cell failure induced by kynurenine, in: Progress in Tryptophan and Serotonin Research 1986, edited by D.A. Bender, M.H. Joseph, W. Kochen and H. Steinhart (Walter de Gruyter, Berlin, New York, 1987), pp.131-136.

    Google Scholar 

  3. V. Rudzite, G. Sileniece, E. Jurika, A. Martinsons, A. Dalmane, V. Groma, and L. Vitolina, Kynurenine and the development of heart and renal pathology, in: Advances in Tryptophan Research 1992, edited by I. Ishiguro, R. Kido, T. Nagatsu, Y. Nagamura and Y.Ohta (Fujita Health University Press, Toyoake. 1992), pp. 379-382.

    Google Scholar 

  4. V. Rudzite, E. lurika, J.  Arajs, and N.  Andrejev, The relationship between kynurenine and arterial blood pressure, in: Progress in Tryptophan and Serotonin Research 1986, edited by D.A. Bender, M.H. Joseph, W. Kochen and H. Steinhart (Walter de Gruyter, Berlin, New York, 1987), pp. I27-130.

    Google Scholar 

  5. E.V. Gorjatchenkova, Viamin B6 (pyridoxine), in: Vitamins,edited by M.J. Smimov (Medicine, Moscow, 1974), pp. 236-263.

    Google Scholar 

  6. R.R. Brown, Tryptophan metabolism in humans: perspectives and prediction, in: Biochemical and Medical Aspects of Tryptophan Metabolism, edited by O. Hayaishi, Y. Ishimura, and R. Kido (North-Holland Biomedical Press, Amsterdam, 1980), pp. 207-235.

    Google Scholar 

  7. D. Bender, Biochemistry of tryptophan in health and disease, Molecular Aspects of Med. 6, 100-197 (1993).

    Google Scholar 

  8. P.M. Ueland, Plasma homocysteine and cardiovascular disease, in: Atherosclerotic Cardiovascular Disease and Endothelial Function edited by R.  Francis (Marcel Dekker, New York, 1990), pp. 183-236.

    Google Scholar 

  9. J.C. Tsai, M.A. Perella, M. Yoshizumi, C.M. Hsieh, E. Haber, R. Schlegel, and M.E. Lee, Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis, Proc. Nat. Acad. Sci. 91, 6369-6373 (1994).

    Article  PubMed  CAS  Google Scholar 

  10. F. Tatzber, H. Rabl, K. Koriska, U. Erhart, H. Puhl, G. Waeg, A. Krebs, and H. Esterbauer, Elevated serum neopterin levels in atherosclerosis, Atherosclerosis 89, 203-208 (1991).

    Article  PubMed  CAS  Google Scholar 

  11. G. Weiss, E. Willert, S. Kiechl, D. Fuchs, E. Jarosch, F. Oberhollenzer, G. Reibnegger, G.P. Tilz, O.F. Gerstenbrand, and H. Wachter, Increased concentration of neopterin in carotid atherosclerosis, Atherosclerosis, 106, 263-271 (1994).

    Article  PubMed  CAS  Google Scholar 

  12. V. Rudzite, J. Jirgensons, E. Jurika, G. Sileniece, R. Zime, and S. Jirgensone, Besonderheiten der Nikotinsäurebildung bei koronarer Herzkrankheit unter Ber¨¹cksichtung von Herzrhythmusstörungen, Z. gesamte inn. Med. 43, 60-65 (1988).

    PubMed  CAS  Google Scholar 

  13. V. Rudzite, G. Sileniece, J. Jirgensons, A. Dalmane, R. Zime, E. Jurika, and J. Skards, The significance of increased kynurenine level in blood to the development of cardiovascular pathology, Acta Medica Baltica 1, 4-19 (1994).

    Google Scholar 

  14. V. Rudzite, E. Jurika, and J. Jirgensons, Changes in membrane fluidity induced by tryptophan and its metabolites, Advances Exp. Med. Biol. 467, 353-367 (1999).

    Article  CAS  Google Scholar 

  15. V. Rudzite, E. Jurika, M. Jäger, D. Fuchs, Impairment of lipid metabolism due to deficiency of pyridoxal-5phosphate and/or activated immune system: its interpretation, Pteridines 11,107-120 (2000).

    CAS  Google Scholar 

  16. J.R. Spies, and D.C. Chambers, Chemical determination of tryptophan. Study of color formation of tryptophan, p-dimethylaminobenzaldehyde and sodium nitrite in sulphuric acid solution, Analytical Chem. 20, 30-39 (1948).

    CAS  Google Scholar 

  17. M.H. Joseph, and D. Risby, The determination of kynurenine in plasma, Clin. Chim. Acta 63, 197-204 (1975).

    Article  PubMed  CAS  Google Scholar 

  18. W.J. Serfontein, J.B. Ubbink, L.S. DeViller, C.H. Rapley, and P.J. Becker, Plasma pyridoxal-5-phosphate level as a risk index for coronary artery disease, Atherosclerosis 55, 357-361 (1985).

    Article  PubMed  CAS  Google Scholar 

  19. T.M. Schipchandler, and E.G. Moore, Rapid, fully automated measurement of plasma homocysteine with the Abbot IMx analyser, Clin.Chem. 41, 991-994 (1995).

    Google Scholar 

  20. H. Rokos and K. Rokos, A radioimmunoassay for the determination of D-erythroneopterin, in: Chemistry and Biology of Pteridines, edited by J.A. Blair (Walter de Gruyter, Berlin, New York,1983), pp.815-8I9.

    Google Scholar 

  21. E. Weber, Grundriss der biologischen Statistik f¨¹r Naturwissenschaftler, Landvirte und Mediziner, (Gustav Fischer Verlag, Jena, 1957).

    Google Scholar 

  22. B.F. Steele, M.S. Reynolds, and C.A. Baumann, Amino acids in blood and urine of human subjects ingesting different amounts of the sanie proteins, J. Nutrition 40, 145-158 (1950).

    CAS  Google Scholar 

  23. E.G. Eccleston, A method for the estimation of free and total acid-soluble plasma tryptophan using an ultrafiltration technique, Clin. Chico. Acta 48, 269-272 (1976).

    Article  Google Scholar 

  24. R.C. Keniston, T. Reyna, W. Becker, M.R. Weir, J.I. Enriquetz Sr, and F. Duncan, Prognostic value of undeproteinizing plasma pyridoxal 5’-phosphate concentrations, in: Clinical and Physiological Applications of vitamin B 6 , edited by J.E. Leklem and R.D. Reynolds (Alan R. Liss Inc., New York,1988), pp. 425-433.

    Google Scholar 

  25. R. Keniston, J. Enriquetz Sr, and I. Delgado, Prognostic value of undeproteinized plasma pyridoxal 5’-phosphate levels in health and disease, Ann. New York Acad. Sci. 585, 496-498 (1990).

    Article  Google Scholar 

  26. D.B. Coursin, Nutritional and clinical aspects, Annals of the New York Acad. Sci. 585, 468-472 (1990).

    Article  CAS  Google Scholar 

  27. Ch. Bolander - Gueaille, Focus on homocysteine (Springer Verlag France, Berlin, Heidelberg, New York, 2001).

    Google Scholar 

  28. A. Meister, Biochemistry of amino acids (Publishing of Foreign Literature, Moscow, 1957).

    Google Scholar 

  29. J.B. Ubbink, A. van der Merwe, R.H. Delport, S.P. Stabler, R. Reizler, W.J. Harward-Vermaak, The effect of subnormal vitamin B6 on homocysteine metabolism, J. Clin. Invest. 98, 177-184 (1996).

    Article  PubMed  CAS  Google Scholar 

  30. F. Binkley, G.M. Christensen, and W.V. Jensen, Pyridoxine and the transfer of sulphur, J. Biol. Chem., 194,101-113 (1952).

    Google Scholar 

  31. L.D. Greenberg, Arteriosclerotic, dental and hepatic lesions in pyridoxine-deficient monkeys, Vitamins and Hormones 22, 677-689 (1964).

    Article  PubMed  CAS  Google Scholar 

  32. G. Alfthan, J. Pekkanen, M. Jauhiainen, J. Pitkaniemi, M. Karvonen, J. Tuomilehto, J.T. Salonen, and C. Ehnoholm, Relation of serum homocysteine and lipoprotein(a) concentration to atherosclerotic disease in a prospective Finnish population based study, Atherosclerosis 106, 9-19 (1994).

    Article  PubMed  CAS  Google Scholar 

  33. P. Verhoeffer, C.H. Hennekens, R.H. Allen, S.P. Stabler, W.C. Willett, and M.J. Stampfer. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery, Am. J. Cardiol. 79, 799-801 (1997).

    Article  Google Scholar 

  34. A.R. Folsom, F.J. Nieto, P.G. McGovern, M.Y. Tsai, M.R. Malinow, J.H. Eckfeldt, D.L. Hess, and C.E. Davis, Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The atherosclerotic risk in Communities (ARIC) study. Circulation 98,196-197 (1998).

    Article  Google Scholar 

  35. V. Rudzite, G. Sileniece, R. Zime, and E. Jurika, Patient with hypertension and ishemic heart disease previuosly treated with antituberculous drugs, Problems of Tuberculosis, Nr.7, 42-46 (1988).

    Google Scholar 

  36. S. Yamoto, and O. Hayaishi, Tryptophan pyrrolase of rabbit intestine (D- and L-tryptophan clearing enzyme and enzymes), J. Biol. Chem. 242, 5260-5266 (1967)

    Google Scholar 

  37. R. Yoshida, U. Urade, M. Toruda, and O. Hayaishi, Induction of indolamine 2,3-dioxigenase in mouse lung during virus infection, Proc. Nail. Acad. Sci. 76, 4084-4086 (1979).

    Article  CAS  Google Scholar 

  38. H. Yasui, K. Takai, R. Yoshida, and O. Hayaishi, Interferon induced tryptophan metabolism by inducing pulmonary indolamine 2,3-dioxigenase: Its possible occurrence in cancer-patients, Proc. Natl. Acad. Sci. 6, 101-197 (1980).

    Google Scholar 

  39. E.R Werner, M. Hirsh-Kaufmann, D. Fuchs, A. Hausen, G. Reibnegger, M. Schweiger, and H. Wachter, Interferon-gamma induced degradation of tryptophan by human cells in vitro, Biol. Chem. HoppeSeyler 368, 1407-1412 (1987).

    CAS  Google Scholar 

  40. E.R. Werner, G. Bitterlich, D. Fuchs, A. Hausen, G. Reibnegger, G. Szabo, M.P. Dierich, and H. Wachter, Human macrophages degrade tryptophan upon induction by interferon-gamma, Life Sci. 41, 273-280 (1987).

    Article  PubMed  CAS  Google Scholar 

  41. C. Huber, J.R. Batchelor, D. Fuchs, A. Hausen, A. Lang, D. Niederwieser, G. Reibnegger, P. Swetly. J. Troppmaier, and H. Wachter, Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma, J. Exp. Med. 160, 3010-3016 (1984).

    Article  Google Scholar 

  42. H. Wachter, D. Fuchs, A. Hausen, G. Reibnegger, G. Weiss, E. R. Werner, G. Werner-Felmayer, Neopterin: biochemistry,methods, clinical application (Walter de Gruyter, Berlin, New York, 1992).

    Google Scholar 

  43. H. Wachter, D. Fuchs, A. Hausen, G. Reibnegger, and E.R. Werner, Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical aplication, Advances in Clinical Chemistry 27, 81-141 (1987).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rudzite, V. et al. (2003). Prognostic Value of Tryptophan Load Test Followed by Serum Kynurenine Determination. It’s Comparison With Pyridoxal-5-phosphate, Kynurenine, Homocysteine and Neopterin Amounts. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0135-0_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4939-6

  • Online ISBN: 978-1-4615-0135-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics